The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - TP Group plc

31 Oct 2022 17:22

RNS Number : 8037E
Science Group PLC
31 October 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Science Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TP Group plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

28 October 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

1p Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

217,923,105

27.97

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

TOTAL:

217,923,105

27.97

Nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

None

 

 

*Denotes those persons acting in concert with Science Group plc, the party to the offer making the disclosure

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

31 October 2022

Contact name:

Sarah Cole

 

Group Legal Counsel & Company Secretary

 

Telephone number:

01223 875 200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEFLFFDIILLVIF
Date   Source Headline
14th May 20147:00 amRNSAGM Statement
2nd May 201412:05 pmRNSDirector Shareholding
22nd Apr 20149:13 amRNSAnnual Financial Report
10th Apr 20143:55 pmRNSGrant of Share Options to Directors
1st Apr 20147:00 amRNSFinal Results
17th Feb 20147:00 amRNSTrading Update
14th Jan 20147:00 amRNSCorac Group secures Defence contracts
19th Dec 201312:07 pmRNSResult of General Meeting and Open Offer
12th Dec 20137:00 amRNSCET signs follow-on renewable energy agreement
10th Dec 20137:00 amRNSContract Win
2nd Dec 20137:00 amRNSPlacing and Open Offer
13th Nov 20137:00 amRNSCET receives BP follow-on order
7th Oct 20137:00 amRNSContract Amendment
25th Sep 20137:00 amRNSGrant of Share Options to a Director
16th Sep 201312:00 pmRNSDirector/PDMR Shareholding
16th Sep 20137:00 amRNSHalf Yearly Report
8th Aug 20137:00 amRNSNotice of Results
30th Jul 20137:00 amRNSContract Win
22nd Jul 20137:00 amRNSDirectorate Change
8th Jul 20137:00 amRNSEnergy Technologies signs Service Agreement
24th Jun 20133:13 pmRNSCorrection to Director/PDMR Shareholding
21st Jun 20139:57 amRNSDirector/PDMR Shareholding
18th Jun 201310:42 amRNSIssue of Equity
18th Jun 201310:32 amRNSIssue of Options
23rd May 20132:01 pmRNSDirector's Dealing
16th May 20133:46 pmRNSResult of AGM
16th May 20137:00 amRNSAGM Trading Update
29th Apr 20137:00 amRNSCET Secure Exploration Project with Tullow Oil
11th Apr 20137:00 amRNSDGC Field Trial Progress Update
26th Mar 20137:00 amRNSDirectorate Change
26th Mar 20137:00 amRNSFinal Results
7th Feb 20137:00 amRNSACI Contract Win
5th Feb 20137:00 amRNSYear End Trading Update & Notice of Results
15th Nov 20127:00 amRNSCET signs joint development & licensing agreement
30th Oct 20127:00 amRNSCorac launches international development programme
18th Oct 20127:00 amRNSCET achieves significant milestone for DGC
17th Oct 20125:55 pmRNSHolding(s) in Company
16th Oct 20127:00 amRNSACI secures international submarine project
4th Oct 20125:47 pmRNSHolding(s) in Company
18th Sep 20127:00 amRNSHalf Yearly Report
6th Sep 20121:57 pmRNSHolding(s) in Company
24th Jul 20127:00 amRNSHalf Year Trading Update and Notice of Results
29th Jun 20127:00 amRNSAnnual Financial Report
28th Jun 20127:00 amRNSCorac Energy Technologies Update
30th May 201210:49 amRNSResult of AGM
29th May 20127:00 amRNSAGM Statement and Business Update
26th Apr 20123:29 pmRNSDirector/PDMR Shareholding
17th Apr 20127:00 amRNSTechnology Update
17th Apr 20127:00 amRNSPreliminary Results
5th Apr 20123:35 pmRNSCompletion of Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.